Kazuo Nishimura

6.4k total citations
260 papers, 3.4k citations indexed

About

Kazuo Nishimura is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Kazuo Nishimura has authored 260 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Pulmonary and Respiratory Medicine, 69 papers in Surgery and 59 papers in Molecular Biology. Recurrent topics in Kazuo Nishimura's work include Prostate Cancer Treatment and Research (56 papers), Renal cell carcinoma treatment (33 papers) and Bladder and Urothelial Cancer Treatments (27 papers). Kazuo Nishimura is often cited by papers focused on Prostate Cancer Treatment and Research (56 papers), Renal cell carcinoma treatment (33 papers) and Bladder and Urothelial Cancer Treatments (27 papers). Kazuo Nishimura collaborates with scholars based in Japan, United States and Netherlands. Kazuo Nishimura's co-authors include Norio Nonomura, Äkïhïko Okuyama, Masashi Nakayama, Yasutomo Nakai, Hitoshi Takayama, Shuyuan Yeh, Akira Tsujimura, Chawnshang Chang, Daizo Oka and Hitoshi Inoue and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Kazuo Nishimura

237 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuo Nishimura Japan 30 1.3k 1.2k 706 661 462 260 3.4k
Kenichi Ohashi Japan 29 939 0.7× 1.3k 1.1× 796 1.1× 747 1.1× 586 1.3× 300 4.1k
Taizo Shiraishi Japan 35 1.4k 1.1× 1.5k 1.2× 904 1.3× 524 0.8× 579 1.3× 145 3.7k
Thomas B. Crotty United States 29 1.4k 1.0× 1.1k 0.9× 553 0.8× 782 1.2× 716 1.5× 64 3.8k
Gaëlle Fromont France 35 2.0k 1.5× 1.7k 1.4× 825 1.2× 1.1k 1.7× 622 1.3× 163 4.8k
Thomas Knösel Germany 38 1.2k 0.9× 1.5k 1.2× 1.6k 2.3× 627 0.9× 618 1.3× 176 4.3k
Arnold M. Schwartz United States 30 610 0.5× 1.1k 0.9× 1.5k 2.1× 586 0.9× 502 1.1× 109 3.6k
Chiung‐Nien Chen Taiwan 36 508 0.4× 1.4k 1.1× 529 0.7× 737 1.1× 540 1.2× 124 3.4k
Angelo Sidoni Italy 32 962 0.7× 1.1k 0.9× 1.2k 1.8× 765 1.2× 712 1.5× 188 3.7k
Rainer Grobholz Germany 39 1.4k 1.1× 1.8k 1.5× 910 1.3× 764 1.2× 966 2.1× 137 4.5k
Hiroshi Kawachi Japan 34 1.0k 0.8× 789 0.6× 1.2k 1.7× 1.0k 1.5× 246 0.5× 157 3.2k

Countries citing papers authored by Kazuo Nishimura

Since Specialization
Citations

This map shows the geographic impact of Kazuo Nishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuo Nishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuo Nishimura more than expected).

Fields of papers citing papers by Kazuo Nishimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuo Nishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuo Nishimura. The network helps show where Kazuo Nishimura may publish in the future.

Co-authorship network of co-authors of Kazuo Nishimura

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuo Nishimura. A scholar is included among the top collaborators of Kazuo Nishimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuo Nishimura. Kazuo Nishimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nishimura, Kazuo. (2023). Management of bone metastasis in prostate cancer. Journal of Bone and Mineral Metabolism. 41(3). 317–326. 6 indexed citations
3.
Yamashita, Shinichi, Ken‐ichi Kakimoto, Motohide Uemura, et al.. (2023). Sexual function using the EORTC QLQ‐TC26 in testicular cancer survivors: A multi‐institutional, cross‐sectional study. International Journal of Urology. 30(11). 1044–1050. 2 indexed citations
4.
Inoue, Satoko, Mayako Uchida, Keiko Fujita, et al.. (2023). Efficacy and safety of mycophenolate mofetil in treating immune‐related hepatitis induced by immune checkpoint inhibitor use: A retrospective study. JGH Open. 7(2). 87–97. 9 indexed citations
5.
Yamashita, Shinichi, Ken‐ichi Kakimoto, Motohide Uemura, et al.. (2022). Association of financial toxicity with quality of life in testicular cancer survivors. International Journal of Urology. 29(12). 1526–1534. 13 indexed citations
6.
Matsubara, Nobuaki, Kazuo Nishimura, Satoru Kawakami, et al.. (2022). Olaparib in patients with mCRPC with homologous recombination repair gene alterations: PROfound Asian subset analysis. Japanese Journal of Clinical Oncology. 52(5). 441–448. 11 indexed citations
7.
Kawahara, Takashi, Koji Kawai, Takahiro Kojima, et al.. (2022). Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo‐refractory germ cell tumors. International Journal of Urology. 29(7). 741–747. 6 indexed citations
8.
Matsumoto, Fumi, Futoshi Matsui, Koji Yazawa, et al.. (2021). Bladder Cancer in a Long-term Survivor of the Prune Belly Syndrome. Urology. 161. 93–95. 1 indexed citations
9.
Okui, Yoshiaki, et al.. (2020). Visco-Elasto-Plastic Analysis for Swelling Ground for Deformed Tunnel. 1 indexed citations
10.
Yasui, Taku, Wataru Shioyama, Toru Oka, et al.. (2020). Acute myocardial infarction caused by tumor embolus originating from upper tract urothelial carcinoma: a case report. Cardio-Oncology. 6(1). 18–18.
11.
Uemura, Hirotsugu, Gaku Arai, Hiroyoshi Suzuki, et al.. (2020). Apalutamide for metastatic, castration‐sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double‐blind, placebo‐controlled phase 3 TITAN study. International Journal of Urology. 28(3). 280–287. 12 indexed citations
13.
Ishizuya, Yu, Koji Hatano, Yasutomo Nakai, et al.. (2016). [A Case of Renal Cell Carcinoma with Malignant Pleural Effusion Showing Marked Response to Axitinib].. Kyoto University Research Information Repository (Kyoto University). 62(10). 525–528. 1 indexed citations
14.
Sumiyoshi, Takayuki, Hiroshi Iwamura, Kenji Mitsumori, et al.. (2013). [Primitive neuroectodermal tumor of kidney : a case report].. PubMed. 59(6). 363–7. 1 indexed citations
15.
Nishimura, Kazuo. (2009). Empirical evaluation of object-oriented programming effectiveness in different types of program. 2009 ICCAS-SICE. 5537–5543. 3 indexed citations
16.
Tsujihata, Masao, et al.. (2008). Clinical Experience with Laparoscopic Radical Nephrectomy for Renal Cell Carcinoma. Urologia Internationalis. 81(3). 301–305. 5 indexed citations
17.
Sano, Nobuo, et al.. (2007). A QUANTITATIVE CRITERION FOR EVALUATION OF TUNNEL LINING CONCRETE. 63(1). 86–96. 2 indexed citations
18.
Oka, Daizo, Kazuo Nishimura, Masahiro Shiba, et al.. (2005). Growth inhibition by Parthenolide in renal cell carcinoma. Cancer Research. 65. 193–193. 1 indexed citations
19.
Nishimura, Kazuo. (1998). Analysis of Millimeter Wave Scattering Characteristics by a Photo-Induced Plasma Grating in a Semiconductor Slab. IEICE Transactions on Electronics. 81(12). 1800–1806. 2 indexed citations
20.
Nakata, Katsuhiko, et al.. (1986). Antihypertensive effects of SA446, hydralazine and the combination on renal hypertensive rats and spontaneously hypertensive rats by long-term treatment.. Folia Pharmacologica Japonica. 87(2). 113–121. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026